Cerus Corporation - Company & Market Research Reports

Cerus Corporation is a biomedical products company focused in the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria and parasites that may be present in donated blood. Cerus Corporation was founded in 1991 and is headquartered in Concord, California.

Blood Screening and Typing Markets - Product Thumbnail Image

Blood Screening and Typing Markets

  • Report
  • 117 Pages
From
From
From
From
From
From
From
From
From
From
Loading Indicator
adroll